CN116925069A - Synthesis method of iron-catalyzed fused ring [1,2-a ] indole compound - Google Patents
Synthesis method of iron-catalyzed fused ring [1,2-a ] indole compound Download PDFInfo
- Publication number
- CN116925069A CN116925069A CN202210375094.5A CN202210375094A CN116925069A CN 116925069 A CN116925069 A CN 116925069A CN 202210375094 A CN202210375094 A CN 202210375094A CN 116925069 A CN116925069 A CN 116925069A
- Authority
- CN
- China
- Prior art keywords
- reaction
- separating
- alkyl
- substituted
- ethyl acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title claims abstract description 13
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 title claims abstract description 12
- -1 indole compound Chemical class 0.000 title claims abstract description 12
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 title claims abstract description 12
- 238000001308 synthesis method Methods 0.000 title description 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 129
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 63
- 239000002904 solvent Substances 0.000 claims abstract description 29
- 238000004440 column chromatography Methods 0.000 claims abstract description 24
- 238000012544 monitoring process Methods 0.000 claims abstract description 24
- 238000010438 heat treatment Methods 0.000 claims abstract description 23
- 238000000926 separation method Methods 0.000 claims abstract description 21
- 239000003054 catalyst Substances 0.000 claims abstract description 17
- 229910052742 iron Inorganic materials 0.000 claims abstract description 16
- 239000003446 ligand Substances 0.000 claims abstract description 10
- 239000003513 alkali Substances 0.000 claims abstract description 9
- 150000002475 indoles Chemical class 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 7
- 238000000605 extraction Methods 0.000 claims abstract description 3
- 238000000746 purification Methods 0.000 claims abstract description 3
- 238000001953 recrystallisation Methods 0.000 claims abstract description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 115
- 239000005725 8-Hydroxyquinoline Substances 0.000 claims description 25
- 229960003540 oxyquinoline Drugs 0.000 claims description 25
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 claims description 25
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 9
- 125000003118 aryl group Chemical group 0.000 claims description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 125000001153 fluoro group Chemical group F* 0.000 claims description 6
- 125000005842 heteroatom Chemical group 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- LFKXWKGYHQXRQA-FDGPNNRMSA-N (z)-4-hydroxypent-3-en-2-one;iron Chemical compound [Fe].C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O LFKXWKGYHQXRQA-FDGPNNRMSA-N 0.000 claims description 3
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 150000001412 amines Chemical group 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 125000004185 ester group Chemical group 0.000 claims description 3
- 125000001072 heteroaryl group Chemical group 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 150000002926 oxygen Chemical class 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- PPTXVXKCQZKFBN-UHFFFAOYSA-N (S)-(-)-1,1'-Bi-2-naphthol Chemical compound C1=CC=C2C(C3=C4C=CC=CC4=CC=C3O)=C(O)C=CC2=C1 PPTXVXKCQZKFBN-UHFFFAOYSA-N 0.000 claims description 2
- DDAPSNKEOHDLKB-UHFFFAOYSA-N 1-(2-aminonaphthalen-1-yl)naphthalen-2-amine Chemical compound C1=CC=C2C(C3=C4C=CC=CC4=CC=C3N)=C(N)C=CC2=C1 DDAPSNKEOHDLKB-UHFFFAOYSA-N 0.000 claims description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- 239000007810 chemical reaction solvent Substances 0.000 claims description 2
- YMHQVDAATAEZLO-UHFFFAOYSA-N cyclohexane-1,1-diamine Chemical compound NC1(N)CCCCC1 YMHQVDAATAEZLO-UHFFFAOYSA-N 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 230000009471 action Effects 0.000 abstract description 2
- 238000007867 post-reaction treatment Methods 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 189
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 63
- 238000005406 washing Methods 0.000 description 61
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 42
- JBXRLVPILRXPNH-UHFFFAOYSA-N indol-6-one Chemical compound O=C1C=CC2=CC=NC2=C1 JBXRLVPILRXPNH-UHFFFAOYSA-N 0.000 description 37
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 21
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 21
- 239000012043 crude product Substances 0.000 description 21
- 150000004698 iron complex Chemical class 0.000 description 21
- 239000003208 petroleum Substances 0.000 description 21
- 239000000047 product Substances 0.000 description 21
- 239000011347 resin Substances 0.000 description 21
- 229920005989 resin Polymers 0.000 description 21
- 239000000741 silica gel Substances 0.000 description 21
- 229910002027 silica gel Inorganic materials 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- 238000007865 diluting Methods 0.000 description 20
- 238000001035 drying Methods 0.000 description 20
- 239000003480 eluent Substances 0.000 description 20
- 238000001914 filtration Methods 0.000 description 20
- 239000012074 organic phase Substances 0.000 description 20
- 239000007787 solid Substances 0.000 description 20
- 238000001816 cooling Methods 0.000 description 19
- 239000011259 mixed solution Substances 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- UBPDKIDWEADHPP-UHFFFAOYSA-N 2-iodoaniline Chemical compound NC1=CC=CC=C1I UBPDKIDWEADHPP-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 2
- 229940067157 phenylhydrazine Drugs 0.000 description 2
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- YAAIPCQYJYPITK-UHFFFAOYSA-N (+)-Aspidospermidine Natural products C1=CC=C2C3(C45)CCN5CCCC4(CC)CCC3NC2=C1 YAAIPCQYJYPITK-UHFFFAOYSA-N 0.000 description 1
- FDNDLNFGITWTOZ-LJQANCHMSA-N (-)-Quebrachamine Chemical compound C([C@@](C1)(CC2)CC)CCN1CCC1=C2NC2=CC=CC=C12 FDNDLNFGITWTOZ-LJQANCHMSA-N 0.000 description 1
- 238000006783 Fischer indole synthesis reaction Methods 0.000 description 1
- 229910021575 Iron(II) bromide Inorganic materials 0.000 description 1
- CKUAXEQHGKSLHN-UHFFFAOYSA-N [C].[N] Chemical compound [C].[N] CKUAXEQHGKSLHN-UHFFFAOYSA-N 0.000 description 1
- YAAIPCQYJYPITK-NCXUSEDFSA-N aspidospermidine Chemical compound C1=CC=C2[C@]3([C@@H]45)CCN5CCC[C@]4(CC)CC[C@H]3NC2=C1 YAAIPCQYJYPITK-NCXUSEDFSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- FDNDLNFGITWTOZ-UHFFFAOYSA-N dl-quebrachamine Natural products C1C(CC)(CC2)CCCN1CCC1=C2NC2=CC=CC=C12 FDNDLNFGITWTOZ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940046149 ferrous bromide Drugs 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- FGFUBBNNYLNVLJ-UHFFFAOYSA-N indol-3-one Chemical compound C1=CC=C2C(=O)C=NC2=C1 FGFUBBNNYLNVLJ-UHFFFAOYSA-N 0.000 description 1
- 150000005629 indol-6-ones Chemical class 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical group Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- GYCHYNMREWYSKH-UHFFFAOYSA-L iron(ii) bromide Chemical compound [Fe+2].[Br-].[Br-] GYCHYNMREWYSKH-UHFFFAOYSA-L 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000004031 phenylhydrazines Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
Abstract
The invention discloses a method for synthesizing an iron-catalyzed fused ring [1,2-a ] indole compound, which comprises the following steps: at room temperature, adding a catalyst A, raw material enaminone, alkali and a solvent into a reaction tube respectively; carrying out reaction under the heating condition, monitoring the reaction progress by TLC, and separating and purifying after the reaction is finished to obtain a condensed ring [1,2-a ] indole compound; wherein catalyst a is a complex of metallic iron/ligand; the reaction temperature is 60 to 120 ℃; separation and purification include, but are not limited to, extraction, column chromatography, recrystallization. The invention takes the commodity with wide sources and low price as the raw material for reaction, synthesizes various substituted condensed ring [1,2-a ] indole compounds under the action of the catalyst of the very cheap iron catalyst, has relatively simple whole reaction condition and convenient post-reaction treatment, and has very good industrialized prospect.
Description
Technical Field
The invention relates to a method for synthesizing an iron-catalyzed fused ring [1,2-a ] indole compound, belonging to the field of organic synthesis.
Background
Condensed ring [1,2-a ] indole compounds widely exist in nature and are core skeletons of alkaloid natural products and drug molecules with important biological activity and medicinal value. [ a) J.am.chem.Soc.1981,103,6990.; b) Chem.pharm.bull.1994,42,2546; c) Angew.Chem., int.Ed.2016,55,13529 ]. Fused ring [1,2-a ] indoles are important intermediates in the synthesis of these active pharmaceutical molecules, such as alkaloid natural products Aspidospermidine, quebrachamine, and the like.
Currently, with respect to fused rings [1,2-a ]]The synthesis method of the indole compound mainly comprises the following steps: (1) Classical Fischer indole synthesis involves the prior formation of phenylhydrazones from substituted phenylhydrazine compounds and 2-substituted 1, 3-cyclohexanediones by intramolecular [3,3]Rearranging and removing one molecule of NH 3 To synthesize [ 1) Tetrahedron lett.1964,5,331; 2) Tetrahedron 1992,48,5991; 3) Tetrahedron 1983,39,3657; 4) Heteromyces 2017,95,1245.]The method is not only limited by the electrical property of phenylhydrazine, but also can synthesize the condensed ring [1,2-a ] rich in electrons]Indole compounds; and are limited by regioselectivity, when meta substituents are present on the phenylhydrazine, fused rings [1,2-a ] are generally obtained]Indole mixtures; (2) Transition metal-participated carbon-nitrogen/carbon-carbon coupling reactions to prepare [ 1) org.lett.2019,21,1082; 2) Adv.synth.catalyst.2010, 352, 2667; 3) Tetrahedron 2013,69,4415; 4) Angew.Chem., int.Ed.2012,51,9891; 5) Org.lett.2018,20,6498; 6) Chem.sci.2013,4,29.]. The main problems of these methods are the use of noble metals as catalysts, or the troublesome synthesis of raw materials, etc.
Therefore, there is a need to develop a synthetic method which is efficient in reaction, wide in raw material sources and inexpensive in catalyst.
Disclosure of Invention
In order to solve the problem of noble metal in the prior art, the invention aims to provide a novel method for synthesizing a fused ring [1,2-a ] indole compound by using a cheap metal iron complex, which takes widely available and cheap commodity as a raw material for reaction, synthesizes various substituted fused ring [1,2-a ] indole compounds under the action of a very cheap iron catalyst, has relatively simple whole reaction condition, is convenient for post-reaction treatment and has very good industrialized prospect. The invention provides a simple, convenient and efficient innovative method for constructing the condensed ring [1,2-a ] indole skeleton, and provides a more novel route selection for synthesizing active molecules containing the skeleton.
In order to achieve the above purpose, the technical scheme of the invention is as follows: a method for synthesizing iron-catalyzed fused ring [1,2-a ] indole compounds comprises the following steps:
catalyst A, raw material enaminone, alkali and solvent are respectively added into a reaction tube at room temperature. And (3) carrying out reaction under the heating condition, monitoring the reaction progress by TLC, and separating and purifying after the reaction is finished to obtain the condensed ring [1,2-a ] indole compound. The reaction process is shown in the equation (I):
the condensed ring [1,2-a ] indole compound has a structure shown in an equation (I) C; the starting enaminone has a structure shown in equation (I) B;
wherein R is 1 Optionally the following structure: hydrogen atom, alkyl, cycloalkyl, heteroatom-containing alkyl, fluoro, chloro, bromoalkyl substituted acyl; cyano group; a nitro group; an ester group; an alkyl or aryl substituted amine; alkyl or aryl substituted oxygen; a substituted silicon-based group;
R 2 is alkyl, cycloalkyl, heteroatom-containing alkyl, aryl, heteroaryl or fluoro;
R 1 is mono-substituted or multi-substituted, and forms a ring or does not form a ring;
wherein X is selected from C or N;
wherein Y is selected from Br, I, OTf, OTs, OSO 2 Ph;
Wherein n is taken from 0, 1, 2;
wherein catalyst a is a complex of metallic iron/ligand;
wherein, the metallic iron is a complex formed by divalent or trivalent iron and a ligand, and the molar ratio of the metallic iron to the ligand is 1:1 to 1:3, wherein the metallic iron comprises Fe (acac) z 、Fe(Cl) z 、Fe(Br) z 、FeI 2 、Fe(OAc) z 、Fe(OTf) z Wherein z=2 or 3; the ligands used are optionally of the structure: ethylenediamine and its derivatives, cyclohexanediamine and its derivatives, BINAM and its derivatives, 8-hydroxyquinoline and its derivatives, BINOL and its derivatives, proline;
preference is given to Fe (acac) 2 And 8-hydroxyquinoline in a molar ratio of 1:2, combining;
wherein the reaction solvent is selected from the following solvents or a combination of solvents: n, N-dimethylformamide, N-dimethylacetamide, tetrahydrofuran, toluene, acetonitrile, dimethylsulfoxide;
dimethyl sulfoxide is preferred;
the alkali is selected from KO t Bu、NaO t Bu、K 2 CO 3 、Cs 2 CO 3 、Na 2 CO 3 、K 3 PO 4 、Na 3 PO 4 、K 2 HPO 4 、KH 2 PO 4 、NaOH、KOH;
The mass ratio of the catalyst A, the enaminone B and the alkali is 0.01:1:1 to 0.1:1:3, a step of;
the reaction temperature is 60 to 120 ℃;
separation and purification include, but are not limited to, extraction, column chromatography, recrystallization.
Compared with the prior art, the synthesis method provided by the invention has the following advantages and beneficial effects:
1) The invention is suitable for the synthesis of condensed ring [1,2-a ] indole compounds containing various substituents, has simple reaction operation and less byproducts, and is easy to purify;
2) The invention has wide sources of raw materials, is cheap and easy to obtain, uses cheap metallic iron as the catalyst, effectively reduces the cost of the catalyst, and has good industrial application prospect.
Drawings
FIGS. 1 and 2 show the starting 3- (2-iodoaniline) -2-methylcyclohexenone according to example 1 of the present invention 1 H NMR 13 CNMR spectrogram;
FIGS. 3 and 4 are diagrams showing 10-methyl-7H-8, 9-o [1,2-a ] produced in example 1 of the present invention]Indol-6-ones 1 H NMR 13 CNMR spectra.
Detailed Description
A further understanding of the nature and advantages of the present invention may be realized by the following detailed description. The examples provided are merely illustrative of the methods of the present invention and are not intended to limit the remainder of the disclosure in any way whatsoever.
The reaction conditions for synthesizing the iron-catalyzed fused ring [1,2-a ] indole compounds are researched by taking 3- (2-iodoaniline) -2-methylcyclohexenone as a standard substrate:
wherein, the iron catalyst represents ferrous chloride, ferrous bromide and ferrous acetylacetonate, the ligand is the structure drawn in the table, mol% refers to relative molar quantity, equiv represents equivalent, alkali represents common inorganic alkali, the organic solvent is anhydrous solvent, and the volume is 2mL. Wherein DMSO is dimethyl sulfoxide, DMF is N, N' -dimethylformamide, n.r. represents no reaction. a is the isolation yield.
Example 1
Preparation of 10-methyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 66.1mg of 3- (2-iodoaniline) -2-methylcyclohexenone (0.2 mmol) and 97.5mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, and performing column chromatography separation on a crude product by using petroleum ether and ethyl acetate mixed solution as eluent (10/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain a target product of 10-methyl-7H-8, 9-o [1,2-a]Indol-6-one (white solid, 35.3 mg), yield: 89%. 1 H NMR(400MHz,CDCl 3 )δ8.47–8.44(m,1H),7.45–7.39(m,1H),7.33–7.24(m,2H),2.89(t,J=6.2Hz,2H),2.76(t,J=6.2Hz,2H),2.18(s,3H),2.11–2.03(m,2H); 13 C NMR(100MHz,CDCl 3 )δ169.3,134.5,133.3,131.2,124.2,123.8,117.8,116.4,112.3,34.6,21.8,21.3,8.6。
Example 2
1, 10-dimethyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 68.6mg of 3- (2-iodo-3-methylaniline) -2-methylcyclohexenone (0.2 mmol) and 97.3mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, carrying out column chromatography separation on a crude product by using petroleum ether and ethyl acetate mixed solution as eluent (10/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain a target product of 1, 10-dimethyl-7H-8, 9-o [1,2-a ]]Indol-6-one (white solid, 33.4 mg), yield: 78%. 1 H NMR(400MHz,CDCl 3 )δ8.35(d,J=8.0Hz,1H),7.18–7.10(m,1H),6.99(d,J=7.3Hz,1H),2.88(t,J=6.3Hz,2H),2.77(t,J=6.5Hz,2H),2.66(s,3H),2.35(s,3H),2.14–2.00(m,2H); 13 C NMR(100MHz,CDCl 3 )δ169.2,135.0,133.1,130.3,129.4,125.6,124.3,114.6,113.2,34.7,21.9,21.3,20.3,11.8。
Example 3
2, 10-dimethyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 68.3mg of 3- (2-iodo-4-methylaniline) -2-methylcyclohexenone (0.2 mmol) and 97.9mg of Cs 2 CO 3 (0.3 mmol) and then 1.8mL of dimethyl sulfoxide solvent are added, the whole reaction is placed on a heating module at 120 ℃ for reaction,TLC monitoring, after the reaction, cooling the whole reaction to room temperature, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in turn, extracting with ethyl acetate three times and separating, washing and separating with water twice, washing and separating with saturated saline water finally, washing and separating with saturated saline water, drying the organic phase with anhydrous sodium sulfate, filtering and concentrating, subjecting the crude product to column chromatography separation with petroleum ether and ethyl acetate mixture as eluent (10/1, v/v) and 200-300 mesh silica gel as separating resin to obtain the target product 2, 10-dimethyl-7H-8, 9-o [1, 2-a)]Indol-6-one (white solid, 36.1 mg), yield: 85%. 1 H NMR(400MHz,CDCl 3 )δ8.30(d,J=8.2Hz,1H),7.21(s,1H),7.11(d,J=8.4Hz,1H),2.87(t,J=6.1Hz,2H),2.77–2.67(m,2H),2.45(s,3H),2.15(s,3H),2.13–2.02(m,2H); 13 C NMR(100MHz,CDCl 3 )δ169.3,133.3,133.1,132.8,131.5,125.4,118.0,116.1,112.0,34.6,21.7,21.4,21.3,8.7。
Example 4
3, 10-dimethyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 68.7mg of 3- (2-iodo-5-methylaniline) -2-methylcyclohexenone (0.2 mmol) and 97.0mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying the organic phase with anhydrous sodium sulfate, filtering and concentrating, subjecting the crude product to column chromatography separation by using petroleum ether and ethyl acetate mixed solution as eluent (10/1, v/v) and using 200-300 mesh silica gel as separating resin to obtainTarget product 3, 10-dimethyl-7H-8, 9-o [1,2-a]Indol-6-one (white solid, 35.9 mg), yield: 84%. 1 H NMR(400MHz,CDCl 3 )δ8.28(s,1H),7.31(d,J=7.8Hz,1H),7.11(d,J=7.8Hz,1H),2.87(t,J=6.1Hz,2H),2.75(t,J=6.1Hz,2H),2.47(s,3H),2.15(s,3H),2.11–2.06(m,2H); 13 C NMR(100MHz,CDCl 3 )δ169.5,134.8,134.3,132.6,129.1,125.2,117.6,116.9,112.3,34.5,21.92,21.88,21.4,8.5。
Example 5
2,4, 10-trimethyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 70.1mg of 3- (2-iodo-4, 6-dimethylaniline) -2-methylcyclohexenone (0.2 mmol) and 96.7mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, carrying out column chromatography separation on a crude product by using petroleum ether and ethyl acetate mixed solution as eluent (10/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain a target product 2,4, 10-trimethyl-7H-8, 9-o [1,2-a ]]Indol-6-one (white solid, 38.1 mg), yield: 84%. 1 H NMR(400MHz,CDCl 3 )δ7.04(s,1H),6.90(s,1H),2.89(t,J=6.3Hz,2H),2.76(t,J=6.3Hz,2H),2.60(s,3H),2.39(s,3H),2.13(s,3H),2.10–2.01(m,2H); 13 C NMR(100MHz,CDCl 3 )δ168.6,134.8,133.9,133.4,132.6,129.1,126.5,115.7,112.5,35.4,23.2,22.5,21.4,21.2,8.8。
Example 6
2-fluoro-10-methyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 69.1mg of 3- (2-iodo-4-fluoroaniline) -2-methylcyclohexenone (0.2 mmol) and 96.5mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, carrying out column chromatography separation on a crude product by using petroleum ether and ethyl acetate mixed solution as eluent (10/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain a target product 2-fluoro-10-methyl-7H-8, 9-o [1,2-a ]]Indol-6-one (white solid, 33.0 mg), yield: 76%. 1 H NMR(400MHz,CDCl 3 )δ8.36(dd,J=9.0,5.0Hz,1H),7.06(dd,J=9.0,2.5Hz,1H),6.99(td,J=9.1,2.6Hz,1H),2.90(t,J=6.0Hz,2H),2.77(t,J=6.0Hz,2H),2.14(s,3H),2.10–2.03(m,2H); 13 C NMR(100MHz,CDCl 3 )δ169.0,160.2(d,J C–F =240.3Hz),135.3,132.4(d,J C–F =9.7Hz),130.8,117.5(d,J C–F =9.2Hz),112.3(d,J C–F =3.9Hz),111.4(d,J C–F =24.8Hz),103.7(d,J C–F =24.0Hz),34.2,21.7,21.3,8.4; 19 F NMR(376MHz,CDCl 3 )δ–119.05。
Example 7
2-chloro-10-methyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 71.8mg of 3- (2-iodo-4-chloroaniline) -2-methylcyclohexenone (0.2 mmol) and 96.3mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, carrying out column chromatography separation on a crude product by using petroleum ether and ethyl acetate mixed solution as eluent (8/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain a target product 2-chloro-10-methyl-7H-8, 9-o [1,2-a ]]Indol-6-one (white solid, 34.5 mg), yield: 74%. 1 H NMR(400MHz,CDCl 3 )δ8.35(d,J=8.8Hz,1H),7.37(d,J=2.1Hz,1H),7.21(dd,J=8.8,2.1Hz,1H),2.92(t,J=6.1Hz,2H),2.78(t,J=6.1Hz,2H),2.14(s,3H),2.11–2.06(m,2H); 13 C NMR(100MHz,CDCl 3 )δ169.1,134.9,132.7,132.5,129.4,124.2,117.9,117.4,111.7,34.5,21.8,21.6,8.6。
Example 8
2-bromo-10-methyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 81.0mg of 3- (2-iodo-4-bromoaniline) -2-methylcyclohexenone (0.2 mmol) and 96.8mg of Cs 2 CO 3 (0.3 mmol), and then adding 1.8mL dimethyl sulfoxide solvent, placing the whole reaction on a 120 ℃ heating module for reaction, monitoring by TLC, and after the reaction is finished, adding the whole reactionCooling to room temperature, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing with water and separating sequentially, extracting with ethyl acetate for three times and separating, washing with water and separating again, washing with saturated saline water and separating finally, drying the organic phase with anhydrous sodium sulfate, filtering and concentrating, subjecting the crude product to column chromatography with petroleum ether and ethyl acetate mixture as eluent (8/1, v/v) and 200-300 mesh silica gel as separating resin to obtain the target product 2-bromo-10-methyl-7H-8, 9-o [1,2-a ]]Indol-6-one (white solid, 41.5 mg), yield: 75%. 1 H NMR(400MHz,CDCl 3 )δ8.28(d,J=8.7Hz,1H),7.54(d,J=2.0Hz,1H),7.35(dd,J=8.7,2.0Hz,1H),2.90(t,J=6.3Hz,2H),2.75(t,J=6.3Hz,2H),2.14(s,3H),2.12–2.06(m,2H); 13 C NMR(100MHz,CDCl 3 )δ169.2,134.6,133.2,133.0,126.8,120.7,117.7,117.1,111.6,34.6,21.8,21.1,8.4。
Example 9
10-methyl-2-trifluoromethyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 79.1mg of 3- (2-iodo-4-trifluoromethylaniline) -2-methylcyclohexenone (0.2 mmol) and 96.8mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, performing column chromatography on the crude product by using petroleum ether and ethyl acetate mixed solution as eluent (5/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain the target product of 10-methyl-2-trifluoromethyl-7H-8, 9-o [1,2-a ]]Indol-6-one (white solid, 36.9 mg), yield: 69%. 1 H NMR(400MHz,CDCl 3 )δ8.30(d,J=8.6Hz,1H),7.52(d,J=2.0Hz,1H),7.36(dd,J=8.6,2.0Hz,1H),2.91(t,J=6.3Hz,2H),2.76(t,J=6.3Hz,2H),2.13(s,3H),2.12–2.06(m,2H); 13 C NMR(100MHz,CDCl 3 )δ169.2,134.8,133.3,133.0,126.8,120.7,117.7,117.1,111.6,34.4,21.7,21.1,8.4; 19 F NMR(376MHz,CDCl 3 )δ–61.00。
Example 10
10-methyl-2-nitro-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 74.3mg of 3- (2-iodo-4-nitroaniline) -2-methylcyclohexenone (0.2 mmol) and 96.6mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, carrying out column chromatography separation on a crude product by using petroleum ether and ethyl acetate mixed solution as eluent (5/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain a target product of 10-methyl-2-nitro-7H-8, 9-o [1,2-a ]]Indol-6-one (yellow solid, 33.4 mg), yield: 69%. 1 H NMR(400MHz,CDCl 3 )δ8.51(d,J=9.1Hz,1H),8.29(d,J=2.2Hz,1H),8.14(dd,J=9.1,2.2Hz,1H),2.97(t,J=6.3Hz,2H),2.81(t,J=6.3Hz,2H),2.24(s,3H),2.19–2.07(m,2H); 13 C NMR(100MHz,CDCl 3 )δ169.6,144.3,137.8,136.6,131.5,119.7,116.4,114.1,112.7,34.6,21.8,21.0,8.5。
Example 11
5-methyl-6H-7, 8-o [3,2-b ] indolizin-9-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 65.5mg of 3- (3-iodo-2-pyridinamine) -2-methylcyclohexenone (0.2 mmol) and 96.0mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, carrying out column chromatography separation on a crude product by using petroleum ether and ethyl acetate mixed solution as eluent (1/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain a target product of 5-methyl-6H-7, 8-o [3,2-b]Indol-9-one (yellow solid, 30.4 mg), yield: 76%. 1 H NMR(400MHz,C 6 D 6 )δ8.51(dd,J=4.6,1.7Hz,1H),7.26(dd,J=7.6,1.7Hz,1H),6.83(dd,J=7.6,4.6Hz,1H),2.17(t,J=6.2Hz,2H),2.00(t,J=6.2Hz,2H),1.73(s,3H),1.18–1.04(m,2H); 13 C NMR(100MHz,C 6 D 6 )δ166.0,148.8,144.6,134.5,125.2,123.6,119.1,108.3,35.1,21.6,20.7,8.0。
Example 12
10-benzyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 80.6mg of 3- (2-iodoaniline) -2-benzylcyclohexenone (0.2 mmol) and 97.0mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, and performing column chromatography separation on a crude product by using petroleum ether and ethyl acetate mixed solution as eluent (10/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain a target product of 10-benzyl-7H-8, 9-o [1,2-a]Indol-6-one (white solid, 33.6 mg), yield: 61%. 1 H NMR(400MHz,CDCl 3 )δ8.49(d,J=8.0Hz,1H),7.37(d,J=8.0Hz,1H),7.31–7.15(m,7H),4.02(s,2H),2.90(t,J=6.3Hz,2H),2.78(t,J=6.3Hz,2H),2.16–2.03(m,2H)。
Example 13
10-phenyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 78.1mg of 3- (2-iodoaniline) -2-phenylcyclohexenone (0.2 mmol) and 96.5mg of Cs 2 CO 3 (0.3 mmol) and continuing to add 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing with water and separating in sequence, extracting with ethyl acetate three times and separating, washing with water and separating, washing with saturated saline water and separating, drying the organic phase with anhydrous sodium sulfate, filtering and concentrating, and taking the crude product as a petroleum ether and ethyl acetate mixed solutionEluting agent (10/1, v/v), and separating by column chromatography with 200-300 mesh silica gel as separating resin to obtain target product 10-phenyl-7H-8, 9-benzo [1,2-a ]]Indol-6-one (white solid, 29.2 mg), yield: 56%. 1 H NMR(400MHz,CDCl 3 )δ8.56–8.53(m,1H),7.62–7.59(m,1H),7.52–7.48(m,4H),7.35–7.19(m,3H),3.06(t,J=6.2Hz,2H),2.85(t,J=6.2Hz,2H),2.11–2.07(m,2H)。
Example 14
10- (4-trifluoromethyl) -phenyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 91.0mg of 3- (2-iodoaniline) -2- (4-trifluoromethyl) phenylcyclohexenone (0.2 mmol) and 96.7mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, carrying out column chromatography separation on a crude product by using petroleum ether and ethyl acetate mixed solution as eluent (5/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain a target product of 10- (4-trifluoromethyl) -phenyl-7H-8, 9-o [1, 2-a)]Indol-6-one (white solid, 39.6 mg), yield: 60%. 1 H NMR(400MHz,CDCl 3 )δ8.57(dd,J=7.5,0.6Hz,1H),7.76(d,J=8.0Hz,2H),7.61(d,J=8.0Hz,2H),7.54(d,J=7.5Hz,1H),7.38–7.29(m,2H),3.06(t,J=6.2Hz,2H),2.87(t,J=6.2Hz,2H),2.15–2.08(m,2H)。
Example 15
10- (4-methoxy) -phenyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 83.4mg of 3- (2-iodoaniline) -2- (4-methoxy) phenylcyclohexenone (0.2 mmol) and 96.2mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, and performing column chromatography separation on a crude product by using petroleum ether and ethyl acetate mixed solution as eluent (5/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain a target product of 10- (4-methoxy) -phenyl-7H-8, 9-o [1, 2-a)]Indol-6-one (white solid, 32.6 mg), yield: 56%. 1 H NMR(400MHz,CDCl 3 )δ8.55(d,J=8.0Hz,1H),7.58(d,J=7.5Hz,1H),7.44–7.41(m,2H),7.36–7.29(m,2H),7.06–7.03(m,2H),3.89(s,3H),3.03(t,J=6.4Hz,2H),2.85(t,J=6.4Hz,2H),2.19–1.99(m,2H)。
Example 16
10-n-butyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 74.0mg of 3- (2-iodoaniline) -2-n-butylcyclohexenone (0.2 mmol) and 96.6mg of Cs 2 CO 3 (0.3 mmol) and then 1.8mL of dimethyl sulfoxide solvent were added, the whole reaction was placed on a 120℃heating module for reaction, and TLC monitoring was performedAfter the reaction is completed, the whole reaction is cooled to room temperature, diluted by ethyl acetate, transferred to a 25mL separating funnel, washed once and separated by water in turn, extracted three times and separated by ethyl acetate, washed twice and separated by water, washed once and separated by saturated saline finally, dried by anhydrous sodium sulfate, filtered and concentrated, the crude product is subjected to column chromatography separation by using petroleum ether and ethyl acetate mixed solution as eluent (10/1, v/v) and 200-300 mesh silica gel as separating resin to obtain the target product 10-n-butyl-7H-8, 9-o [1,2-a]Indol-6-one (white solid, 30.8 mg), yield: 64%. 1 H NMR(400MHz,CDCl 3 )δ8.46–8.44(m,1H),7.44–7.42(m,1H),7.28–7.24(m,2H),2.88(t,J=6.4Hz,2H),2.76(t,J=6.4Hz,2H),2.61(t,J=7.5Hz,2H),2.08–2.03(m,2H),1.63–1.54(m,2H),1.40–1.31(m,2H),0.93(t,J=7.3Hz,3H); 13 C NMR(100MHz,CDCl 3 )δ169.5,134.6,133.3,130.7,124.0,123.7,118.2,117.4,116.5,34.7,32.0,23.7,22.6,22.1,21.4,14.0。
Example 17
2- (6, 7,8, 9-Tetrahydropyrido [1,2-a ] indol-6-one) -acetic acid tert-butyl ester
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol 8-hydroxyquinoline), 85.0mg tert-butyl 2- (2- ((2-iodophenyl) amino) -6-oxocyclohex-1-en-1-yl) acetate (0.2 mmol) and 96.9mg Cs 2 CO 3 (0.3 mmol) and continuing to add 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing with water and separating in sequence, extracting with ethyl acetate three times and separating, washing with water and separating, washing with saturated saline water and separating, drying the organic phase with anhydrous sodium sulfate, filtering and concentrating, and separating the crude product with petroleum ether and ethyl acetateThe ethyl acetate mixed solution is used as eluent (5/1, v/v), and 200-300 mesh silica gel is used as separation resin to carry out column chromatography separation to obtain the target product 2- (6, 7,8, 9-tetrahydropyrido [1, 2-a)]Indol-6-one) -acetic acid tert-butyl ester (white solid, 31.1 mg), yield: 52%. 1 H NMR(400MHz,CDCl 3 )δ8.47–8.45(m,1H),7.51–7.48(m,1H),7.32–7.26(m,2H),3.56(s,2H),2.98(t,J=7.5Hz,2H),2.79(t,J=7.5Hz,2H),2.11–2.09(m,2H),1.41(s,9H); 13 C NMR(100MHz,CDCl 3 )δ170.3,169.6,135.5,134.7,130.0,124.5,124.1,118.3,116.5,110.5,34.6,31.8,28.3,22.0,21.1。
Example 18
9-methyl-3H-1, 2-dihydropyrrolo [1,2-a ] indol-3-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 62.8mg of 3- (2-iodoaniline) -2-methylcyclopentenone (0.2 mmol) and 96.7mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, carrying out column chromatography separation on a crude product by using petroleum ether and ethyl acetate mixed solution as eluent (10/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain a target product of 9-methyl-3H-1, 2-dihydropyrrolo [1,2-a ]]Indol-3-one (white solid, 28.1 mg), yield: 76%. 1 H NMR(400MHz,CDCl 3 )δ8.07–8.05(m,1H),7.51–7.35(m,1H),7.31–7.25(m,2H),3.09(m,4H),2.20(s,3H); 13 C NMR(100MHz,CDCl 3 )δ171.6,139.3,136.4,130.5,123.8,123.4,118.6,113.7,108.9,35.0,18.6,8.3。
Example 19
10-allyl-7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 70.7mg of 3- (2-iodoaniline) -2-allylcyclohexenone (0.2 mmol) and 96.9mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, carrying out column chromatography separation on a crude product by using petroleum ether and ethyl acetate mixed solution as eluent (10/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain a target product of 10-allyl-7H-8, 9-o [1,2-a ]]Indol-6-one (white solid, 35.0 mg), yield: 78%. 1 H NMR(400MHz,CDCl 3 )δ8.51–8.41(m,1H),7.50–7.37(m,1H),7.34–7.18(m,2H),5.96–5.91(m,1H),5.24–4.87(m,2H),3.39(d,J=6.0Hz,2H),2.88(t,J=6.0Hz,2H),2.76(t,J=6.4Hz,2H),2.07(p,J=6.4Hz,2H); 13 C NMR(100MHz,CDCl 3 )δ169.5,135.7,134.6,134.0,130.3,124.2,123.7,118.3,116.5,115.6,114.3,34.5,28.3,21.8,21.1。
Example 20
10-cinnamyl-7H-8, 9-o [1,2-a ] indol-6-one
To the reaction tube previously dried, 0.2mL of metallic iron was added to complex eachDMSO solution of the substance (containing 0.02mmol Fe (acac)) 2 And 0.04mmol of 8-hydroxyquinoline), 85.4mg of 3- (2-iodoaniline) -2-cinnamyl cyclohexenone (0.2 mmol) and 96.3mg of Cs 2 CO 3 (0.3 mmol) and then adding 1.8mL of dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished, diluting with ethyl acetate, transferring to a 25mL separating funnel, washing and separating with water in sequence, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water finally and separating, drying an organic phase with anhydrous sodium sulfate, filtering and concentrating, and performing column chromatography separation on a crude product by using petroleum ether and ethyl acetate mixed solution as eluent (10/1, v/v) and using 200-300 mesh silica gel as separating resin to obtain a target product of 10-cinnamyl-7H-8, 9-o [1,2-a]Indol-6-one (yellow oily liquid, 37.9 mg), yield: 63%. 1 H NMR(400MHz,CDCl 3 )δ8.54–8.46(m,1H),7.50(dd,J=7.3,1.6Hz,1H),7.37–7.29(m,6H),7.26–7.18(m,1H),6.51–6.44(m,1H),6.40–6.28(m,1H),3.60(dd,J=6.1,1.5Hz,2H),2.98(t,J=6.3Hz,2H),2.80(t,J=6.3Hz,2H),2.16–2.10(m,2H); 13 C NMR(100MHz,CDCl 3 )δ169.5,137.4,134.7,134.3,130.7,130.3,128.7,127.4,127.3,126.1,124.5,123.8,118.2,116.5,114.5,34.6,27.6,22.1,21.2。
Example 21
10- (3-methyl-2-butenyl) -7H-8, 9-o [1,2-a ] indol-6-one
To the previously dried reaction tubes, 0.2mL of DMSO solution of metallic iron complex (containing 0.02mmol of Fe (acac)) was added, respectively 2 And 0.04mmol of 8-hydroxyquinoline), 76.0mg of 3- (2-iodoaniline) -2- (3-methyl-2-butenyl) cyclohexenone (0.2 mmol) and 96.6mg of Cs 2 CO 3 (0.3 mmol), then adding 1.8mL dimethyl sulfoxide solvent, placing the whole reaction on a heating module at 120 ℃ for reaction, monitoring by TLC, cooling the whole reaction to room temperature after the reaction is finished,diluting with ethyl acetate, transferring to 25mL separating funnel, sequentially washing with water and separating, extracting with ethyl acetate three times and separating, washing with water twice and separating, washing with saturated saline water and separating, drying the organic phase with anhydrous sodium sulfate, filtering and concentrating, subjecting the crude product to column chromatography with petroleum ether and ethyl acetate mixed solution as eluent (10/1, v/v) and 200-300 mesh silica gel as separating resin to obtain target product 10- (3-methyl-2-butenyl) -7H-8, 9-o [1, 2-a)]Indol-6-one (white solid, 38.1 mg), yield: 75%. 1 HNMR(400MHz,CDCl 3 )δ8.41–8.32(m,1H),7.41–7.31(m,1H),7.26–7.13(m,2H),5.18–5.13(m,1H),3.26(d,J=7.0Hz,2H),2.90–2.78(m,2H),2.75–2.62(m,2H),2.03–1.98(m,2H),1.74(s,3H),1.67–1.60(m,3H); 13 C NMR(100MHz,CDCl 3 )δ169.5,134.8,133.3,132.3,130.6,124.3,123.9,122.0,118.4,116.4,116.3,34.6,25.9,23.0,21.9,21.2,18.0。
The above-described embodiments of the present invention do not limit the scope of the present invention. Any other corresponding changes and modifications made in accordance with the technical idea of the present invention shall be included in the scope of the claims of the present invention.
Claims (2)
1. Condensed ring [1,2-a ] indole compounds of the formula:
wherein R is 1 Optionally the following structure: hydrogen atom, alkyl, cycloalkyl, heteroatom-containing alkyl, fluoro, chloro, bromoalkyl substituted acyl; cyano group; a nitro group; an ester group; an alkyl or aryl substituted amine; alkyl or aryl substituted oxygen; a substituted silicon-based group;
R 2 is alkyl, cycloalkyl, heteroatom-containing alkyl, aryl, heteroaryl or fluoro;
R 1 is mono-substituted or multi-substituted, and forms a ring or does not form a ring;
wherein X is selected from C or N;
wherein n is taken from 0, 1, 2.
2. A method for synthesizing an iron-catalyzed fused ring [1,2-a ] indole compound is characterized by comprising the following steps:
at room temperature, adding a catalyst A, raw material enaminone, alkali and a solvent into a reaction tube respectively;
carrying out reaction under the heating condition, monitoring the reaction progress by TLC, and separating and purifying after the reaction is finished to obtain a condensed ring [1,2-a ] indole compound;
the reaction equation is shown below:
wherein R is 1 Optionally the following structure: hydrogen atom, alkyl, cycloalkyl, heteroatom-containing alkyl, fluoro, chloro, bromoalkyl substituted acyl; cyano group; a nitro group; an ester group; an alkyl or aryl substituted amine; alkyl or aryl substituted oxygen; a substituted silicon-based group; r is R 2 Is alkyl, cycloalkyl, heteroatom-containing alkyl, aryl, heteroaryl or fluoro; r is R 1 Is mono-substituted or multi-substituted, and forms a ring or does not form a ring;
wherein X is selected from C or N;
wherein Y is selected from Br, I, OTf, OTs, OSO 2 Ph;
Wherein n is taken from 0, 1, 2;
wherein catalyst a is a complex of metallic iron/ligand;
wherein, the metallic iron is a complex formed by divalent or trivalent iron and a ligand, and the molar ratio of the metallic iron to the ligand is 1:1 to 1:3, metallic iron includes Fe (acac) z 、Fe(Cl) z 、Fe(Br) z 、FeI 2 、Fe(OAc) z 、Fe(OTf) z Wherein z=2 or 3;
the ligands used are optionally of the structure: ethylenediamine and its derivatives, cyclohexanediamine and its derivatives, BINAM and its derivatives, 8-hydroxyquinoline and its derivatives, BINOL and its derivatives, proline;
preference is given to Fe (acac) 2 And 8-hydroxyquinoline in a molar ratio of 1:2, combining;
wherein the reaction solvent is selected from the following solvents or a combination of solvents: n, N-dimethylformamide, N-dimethylacetamide, tetrahydrofuran, toluene, acetonitrile, dimethylsulfoxide;
dimethyl sulfoxide is preferred;
the alkali is selected from KO t Bu、NaO t Bu、K 2 CO 3 、Cs 2 CO 3 、Na 2 CO 3 、K 3 PO 4 、Na 3 PO 4 、K 2 HPO 4 、KH 2 PO 4 、NaOH、KOH;
The mass ratio of the catalyst A, the enaminone B and the alkali is 0.01:1:1 to 0.1:1:3, a step of;
the reaction temperature is 60 to 120 ℃;
separation and purification include, but are not limited to, extraction, column chromatography, recrystallization.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210375094.5A CN116925069A (en) | 2022-04-11 | 2022-04-11 | Synthesis method of iron-catalyzed fused ring [1,2-a ] indole compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210375094.5A CN116925069A (en) | 2022-04-11 | 2022-04-11 | Synthesis method of iron-catalyzed fused ring [1,2-a ] indole compound |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116925069A true CN116925069A (en) | 2023-10-24 |
Family
ID=88391361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210375094.5A Pending CN116925069A (en) | 2022-04-11 | 2022-04-11 | Synthesis method of iron-catalyzed fused ring [1,2-a ] indole compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116925069A (en) |
-
2022
- 2022-04-11 CN CN202210375094.5A patent/CN116925069A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111978265B (en) | Preparation method of 5-trifluoromethyl substituted 1,2, 4-triazole derivative | |
CN113024556A (en) | Preparation method of fused ring compound containing indole skeleton | |
Yuan et al. | One pot synthesis of pyrrolo [3, 2, 1-de] phenanthridines from 7-phenylindoles via tandem C–H olefination/aza-Michael addition | |
CN108863890B (en) | 4-pyrroline-2-ketone derivative and preparation method thereof | |
CN108912044B (en) | Method for synthesizing polysubstituted pyridine by using copper-catalyzed alkenyl azide | |
WO2022156025A1 (en) | SYNTHESIS METHOD FOR 4-(2,2,2-TRICHLOROETHYL)-β-LACTAM DERIVATIVE | |
Xia et al. | Platinum-catalyzed 1, 3-acyloxy migration/[1, 5]-hydride transfer/cycloaddition sequence: synthesis of ring-fused tetrahydroquinolines | |
CN116925069A (en) | Synthesis method of iron-catalyzed fused ring [1,2-a ] indole compound | |
CN113511986B (en) | Preparation method of aryl acetonitrile derivative | |
CN109369647B (en) | Synthesis method of fused ring [1,2-a ] indole compound and 2, 3-disubstituted indole compound | |
CN109422685A (en) | A kind of synthetic method of N- acetyl group phenanthridines -6- amide and its derivative | |
JP2008531487A (en) | A new synthesis of camptothecin subunits. | |
CN113880781A (en) | Method for synthesizing 3-trifluoromethyl substituted 1,2, 4-triazole compound by taking glucose as carbon source | |
CN111018779B (en) | 2- (3-isoquinolyl) -ethyl propionate derivative and synthetic method thereof | |
CN114195703A (en) | Method for synthesizing difluoromethylene alkane-containing compound | |
CN114957097B (en) | Preparation method of indoline compound | |
CN114349684B (en) | Synthetic method of benzo [ c, d ] indole imine derivative | |
CN110467613B (en) | Reaction method for alkylation of imide cation intramolecular amide by nickel catalysis | |
CN111285846B (en) | 2- (2-indolyl) -acetate derivative and synthesis method thereof | |
CN114989065B (en) | Preparation method of indole dimer compound | |
CN112724042B (en) | Synthesis method of one-pot polysubstituted decalin derivative | |
CN112778203B (en) | Process for the preparation of 1H-indazole-3-carboxylic acid derivatives and granisetron and lonidamine | |
CN110759923B (en) | Pyrimidopyrrolopyridazine derivatives, intermediates thereof, preparation method, pharmaceutical compositions and uses | |
CN114195726B (en) | Preparation method of 1,2, 4-triazole substituted arylamine compound | |
CN110357879B (en) | Preparation method of C-3 benzyl indolizine compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |